Literature DB >> 30726761

Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis.

Saul Soberanes, Alexander V Misharin, Amit Jairaman, Luisa Morales-Nebreda, Alexandra C McQuattie-Pimentel, Takugo Cho, Robert B Hamanaka, Angelo Y Meliton, Paul A Reyfman, James M Walter, Ching-I Chen, Monica Chi, Stephen Chiu, Francisco J Gonzalez-Gonzalez, Matthew Antalek, Hiam Abdala-Valencia, Sergio E Chiarella, Kaitlyn A Sun, Parker S Woods, Andrew J Ghio, Manu Jain, Harris Perlman, Karen M Ridge, Richard I Morimoto, Jacob I Sznajder, William E Balch, Sangeeta M Bhorade, Ankit Bharat, Murali Prakriya, Navdeep S Chandel, Gökhan M Mutlu, G R Scott Budinger.   

Abstract

Entities:  

Year:  2019        PMID： 30726761      PMCID： PMC6377562          DOI： 10.1016/j.cmet.2018.12.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


× No keyword cloud information.
  6 in total

Review 1.  The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities.

Authors:  Jiaqi Lin; Jinxuan Ren; Dave Schwinn Gao; Yi Dai; Lina Yu
Journal:  Front Chem       Date:  2021-05-12       Impact factor: 5.221

2.  Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response.

Authors:  Kaitlyn A Sun; Yan Li; Angelo Y Meliton; Parker S Woods; Lucas M Kimmig; Rengül Cetin-Atalay; Robert B Hamanaka; Gökhan M Mutlu
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

Review 3.  Role of Mitochondria in the Redox Signaling Network and Its Outcomes in High Impact Inflammatory Syndromes.

Authors:  Natalia D Magnani; Timoteo Marchini; Valeria Calabró; Silvia Alvarez; Pablo Evelson
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-23       Impact factor: 5.555

4.  Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.

Authors:  Rogan A Grant; Luisa Morales-Nebreda; Nikolay S Markov; Suchitra Swaminathan; Melissa Querrey; Estefany R Guzman; Darryl A Abbott; Helen K Donnelly; Alvaro Donayre; Isaac A Goldberg; Zasu M Klug; Nicole Borkowski; Ziyan Lu; Hermon Kihshen; Yuliya Politanska; Lango Sichizya; Mengjia Kang; Ali Shilatifard; Chao Qi; Jon W Lomasney; A Christine Argento; Jacqueline M Kruser; Elizabeth S Malsin; Chiagozie O Pickens; Sean B Smith; James M Walter; Anna E Pawlowski; Daniel Schneider; Prasanth Nannapaneni; Hiam Abdala-Valencia; Ankit Bharat; Cara J Gottardi; G R Scott Budinger; Alexander V Misharin; Benjamin D Singer; Richard G Wunderink
Journal:  Nature       Date:  2021-01-11       Impact factor: 69.504

5.  Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial.

Authors:  Charles Bruen; Mukhtar Al-Saadi; Peter C Hou; Edward A Michelson; Maged Tanios; Raul Mendoza-Ayala; Joseph Miller; Jeffrey Zhang; Kenneth Stauderman; Sudarshan Hebbar
Journal:  Crit Care       Date:  2022-04-08       Impact factor: 9.097

Review 6.  Distinctive features of severe SARS-CoV-2 pneumonia.

Authors:  G R Scott Budinger; Alexander V Misharin; Karen M Ridge; Benjamin D Singer; Richard G Wunderink
Journal:  J Clin Invest       Date:  2021-07-15       Impact factor: 19.456
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.